This randomised controlled study investigated a novel combination of two medications (dronabinol + acetazolamide = IHL-42X) at three doses for the treatment of #OSA. The findings demonstrate that IHL-42X reduced #OSA severity by 35-40%, regardless of dose. https://academic.oup.com/sleep/advance-article/doi/10.1093/sleep/zsae276/7908945